Tang Capital Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.44M | Hold |
1,121,138
| – | – | 0.43% | 61 |
|
|
2025
Q1 | $8.49M | Buy |
1,121,138
+200,000
| +22% | +$1.51M | 0.47% | 52 |
|
|
2024
Q4 | $11.2M | Hold |
921,138
| – | – | 0.74% | 38 |
|
|
2024
Q3 | $15.4M | Hold |
921,138
| – | – | 1.1% | 29 |
|
|
2024
Q2 | $16.1M | Buy |
921,138
+350,000
| +61% | +$6.1M | 1.64% | 18 |
|
|
2024
Q1 | $9.73M | Sell |
571,138
-200,000
| -26% | -$3.41M | 1.01% | 34 |
|
|
2023
Q4 | $7.86M | Buy |
771,138
+150,000
| +24% | +$1.53M | 0.73% | 37 |
|
|
2023
Q3 | $5.62M | Buy |
621,138
+171,138
| +38% | +$1.55M | 0.79% | 39 |
|
|
2023
Q2 | $4.84M | Sell |
450,000
-50,000
| -10% | -$538K | 0.71% | 37 |
|
|
2023
Q1 | $5.12M | Sell |
500,000
-309,231
| -38% | -$3.16M | 0.76% | 39 |
|
|
2022
Q4 | $8.54M | Buy |
809,231
+185,215
| +30% | +$1.95M | 1.24% | 25 |
|
|
2022
Q3 | $8M | Buy |
624,016
+14,785
| +2% | +$190K | 0.98% | 31 |
|
|
2022
Q2 | $7.81M | Buy |
+609,231
| New | +$7.81M | 1.19% | 22 |
|